Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Share Options

6 Mar 2014 07:00

RNS Number : 6379B
TyraTech, Inc.
06 March 2014
 



 

 TYRATECH, INC.

 

("TyraTech" or "the Company")

 

Award of Share Options6 March 2014

 

 

TyraTech, Inc. (AIM: TYR), a natural life sciences company, announces that on 4 March 2013, a total of 2,500,000 Stock Appreciation Right options over common shares of US$0.001 in the Company ("SARs"), were awarded to the directors of the Company (the "Award").

Of the SARs awarded, Bruno Jactel, Alan Reade, Barry Riley and James Hills, directors of the Company, were awarded 1,500,000, 500,000, 250,000 and 250,000 SARs, respectively.

The Company now has a total of 10,676,909 SARs outstanding over Common shares.

Following the Award:

Bruno Jactel is interested in 1,859,567 Common Shares representing an interest of 0.90 per cent. of the total voting rights of the Company. In addition, Bruno Jactel is interested in 1,500,000 SARs in the Company as follows:

Options Held

Option Exercise Price

Expiry Date

1,500,000

12.5p

4 March 2024

Alan Reade is interested in 12,486,358 Common Shares representing an interest of 6.06 per cent. of the total voting rights of the Company. In addition, Alan Reade is interested in 3,145,695 SARs in the Company as follows:

Options Held

Option Exercise Price

Expiry Date

500,000

12.5p

4 March 2024

1,000,000

6p

25 April 2022

100,570

12p

6 March 2022

550,000

10.5p

4 February 2020

995,125

12p

10 October 2020

Barry Riley is interested in 3,055,556 Common Shares in the Company representing an interest of up to 1.48 per cent. of the total voting rights of the Company. In addition, Barry Riley is interested in 800,000 SARs in the Company as follows:

Options Held

Option Exercise Price

Expiry Date

250,000

12.5p

4 March 2024

350,000

6p

25 April 2022

200,000

12p

10 October 2020

 

 

James Hills is interested in 1,047,900 Common Shares in the Company representing an interest of up to 0.51 per cent. of the total voting rights of the Company. In addition, James Hills is interested in 800,000 SARs in the Company as follows:

Options Held

Option Exercise Price

Expiry Date

250,000

12.5p

4 March 2024

350,000

6p

25 April 2022

200,000

12p

10 October 2020

 

 

TyraTech, Inc.

Alan Reade, Executive Chairman Tel: +1 919 415 4310

Peter Jerome, Chief Financial Officer Tel: +1 919 415 4280

 

SPARK Advisory Partners Limited, Nominated Adviser Matt Davis Tel: +44203 368 3552

Mark Brady Tel: +44203 368 3551

 

Allenby Capital Limited, Joint BrokerChris Crawford Tel: +44 20 3328 5656

Whitman Howard Limited, Joint BrokerRanald McGregor Smith / Niall Devins Tel: +44 20 7087 4555

Walbrook, Financial PR and IRBob Huxford /Guy McDougall (Public Relations) Tel: +44 20 7933 8792Paul Cornelius (Investor Relations) Tel: +44 20 7933 8794

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCGDXRUGBGSU
Date   Source Headline
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20184:35 pmRNSPrice Monitoring Extension
28th Sep 20182:06 pmRNSSecond Price Monitoring Extn
28th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Sep 201811:05 amRNSSecond Price Monitoring Extn
28th Sep 201811:00 amRNSPrice Monitoring Extension
28th Sep 20189:05 amRNSSecond Price Monitoring Extn
28th Sep 20189:00 amRNSPrice Monitoring Extension
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.